ANAB vs MAS · rev $234.6M vs P/E 18, rev $7.56B
AnaptysBio Inc (ANAB) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
ANAB currently screens at market cap $1.62B. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the ANAB and MAS stock pages for the full models.
Not investment advice.